Allergy to bumblebee venom. III. Immunotherapy follow-up study (safety and efficacy) in patients with occupational bumblebee-venom anaphylaxis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 9, 1999, Pages 980-984

  De Jong, N W ^a   Vermeulen, A M ^a   De Groot, H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anaphylaxis; Bumblebee venom; Efficacy; Hymenoptera; Immunotherapy; Safety

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BEE VENOM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLEMASTINE; CORTICOSTEROID;

ANAPHYLAXIS; ANTIBODY TITER; ARTICLE; BRONCHUS HYPERREACTIVITY; CROSS REACTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; SKIN TEST;

ADULT; ANAPHYLAXIS; BEE VENOMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; SKIN TESTS; TREATMENT OUTCOME;

EID: 0032848837     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00158.x     Document Type: Article

References (13)

1. Müller UR. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart: G. Fischer Verlag, 1990.
2. Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966;3:331-333.
3. de Groot H, de Graaf-in 't Veld C, Gerth van Wijk R. Allergy to bumblebee venom. I. Occupational anaphylaxis to bumblebee venom: diagnosis and treatment. Allergy 1995;50:581-584.
4. Norman PS. Skin testing. In: Rose NR, Friedman H, editors. Manual of clinical immunology. 2nd ed. Washington, DC: American Society for Microbiology, 1980:189-193.
5. Müller U, Mosbech H. Position paper: Immunotherapy with Hymenoptera venoms. Allergy 1993;48 Suppl 14:37-46.
6. Hoffman DR, Jacobsen RS. Allergens in Hymenoptera venom. XXVII. Bumblebee venom allergy and allergens. J Allergy Clin Immunol 1996;97:812-821.
7. Jacobson RS, Hoffman DR. Characterization of bumblebee venom allergens. Allergy 1992;91:185.
8. Kochuyt AM, Hoeyveld E, Stevens EAM. Occupational allergy to bumblebee venom. Clin Exp Allergy 1992;23:190-195.
9. Stapel SO, Waanders-Lijster de Raadt J, Toorenenbergen AW, Groot H. Allergy to bumblebee venom. Il. IgE cross-reactivity between humblebee and honeybee venom. Allergy 1998;53:769-777.
10. Stern A, Müllner G, Wüthrich B. Diagnosis and treatment of occupational allergy to bumblebees. Allergy 1998;53 Suppl 43:27.
11. Birnhaum J, Charpin D, Vervloet D. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy 1993;23:226-230.
12. Franken HH, Dubois AEJ, Minkema HJ, vd Heide S, de Monchy JGR. Lack of reproducibility of a single negative sting challenge in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 1994;93:431-436.
13. Mosbech H. Hymenoptera immunotherapy. Allergy 1997;52:1-3.